These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 20676325)
1. Identification of novel methylation markers in hepatocellular carcinoma using a methylation array. Shin SH; Kim BH; Jang JJ; Suh KS; Kang GH J Korean Med Sci; 2010 Aug; 25(8):1152-9. PubMed ID: 20676325 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. Jung N; Won JK; Kim BH; Suh KS; Jang JJ; Kang GH J Korean Med Sci; 2012 Jun; 27(6):594-604. PubMed ID: 22690089 [TBL] [Abstract][Full Text] [Related]
3. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma. Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
5. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435 [TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma. Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083 [TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. Cai HH; Sun YM; Miao Y; Gao WT; Peng Q; Yao J; Zhao HL Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):95-100. PubMed ID: 21269942 [TBL] [Abstract][Full Text] [Related]
8. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334 [TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer. Cheng Y; Kim JW; Liu W; Dunn TA; Luo J; Loza MJ; Kim ST; Zheng SL; Xu J; Isaacs WB; Chang BL Prostate; 2009 Feb; 69(3):327-35. PubMed ID: 19035483 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma. Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538 [TBL] [Abstract][Full Text] [Related]
12. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines]. Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987 [TBL] [Abstract][Full Text] [Related]
13. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
15. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma. Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447 [TBL] [Abstract][Full Text] [Related]
16. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900 [TBL] [Abstract][Full Text] [Related]
19. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062 [TBL] [Abstract][Full Text] [Related]
20. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]